(Q34084610)

30 July 2017

title

Molecular targets for autoimmune and genetic disorders of neuromuscular transmission (English)

1 reference

30 July 2017

A Vincent

1

1 reference

30 July 2017

D Beeson

series ordinal

2

1 reference

30 July 2017

B Lang

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

267

1 reference

30 July 2017

issue

23

1 reference

30 July 2017

page(s)

6717-6728

1 reference

Synaptic structure and development: the neuromuscular junction

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Formation of the neuromuscular junction. Agrin and its unusual receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Development of the vertebrate neuromuscular junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

beta-Spectrin is colocalized with both voltage-gated sodium channels and ankyrinG at the adult rat neuromuscular junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

The postsynaptic 43k protein clusters muscle nicotinic acetylcholine receptors in xenopus oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Calcium channel diversity and neurotransmitter release: the omega-conotoxins and omega-agatoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Effects of the potassium channel blocking dendrotoxins on acetylcholine release and motor nerve terminal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

The emerging three-dimensional structure of a receptor. The nicotinic acetylcholine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Nicotinic acetylcholine receptor at 4.6 A resolution: transverse tunnels in the channel wall.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Alpha-Bungarotoxin binding to human muscle acetylcholine receptor: measurement of affinity, delineation of AChR subunit residues crucial to binding, and protection of AChR function by synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Location of antigenic determinants on primary sequences of subunits of nicotinic acetylcholine receptor by peptide mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

AN ELECTROPHYSIOLOGICAL INVESTIGATION OF NEUROMUSCULAR TRANSMISSION IN MYASTHENIA GRAVIS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Autoimmune Response to Acetylcholine Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Molecular structure of the nicotinic acetylcholine receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Neuromuscular Junction in Myasthenia Gravis: Decreased Acetylcholine Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Acetylcholine receptor turnover in mice with passively transferred myasthenia gravis. II. Receptor synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Regulation of acetylcholine receptor alpha subunit variants in human myasthenia gravis. Quantification of steady-state levels of messenger RNA in muscle biopsy using the polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

The membrane attack complex of complement at the endplate in myasthenia gravis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Association of neonatal myasthenia gravis with antibodies against the fetal acetylcholine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Plasma from human mothers of fetuses with severe arthrogryposis multiplex congenita causes deformities in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Calcitonin gene-related peptide enhances the rate of desensitization of the nicotinic acetylcholine receptor in cultured mouse muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

The Lambert-Eaton myasthenic syndrome. A review of 50 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Lambert-Eaton myasthenic syndrome: II. Immunoelectron microscopy localization of IgG at the mouse motor end-plate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Distribution and functional significance of the P-type, voltage-dependent Ca2+ channels in the mammalian central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

The role of autoantibodies in Lambert-Eaton myasthenic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

An improved diagnostic assay for Lambert-Eaton myasthenic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Human autoantibodies specific for the alpha1A calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Immunological associations of acquired neuromyotonia (Isaacs' syndrome). Report of five cases and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Congenital myasthenia: end-plate acetylcholine receptors and electrophysiology in five cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Congenital myasthenic syndromes: recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Novel functional epsilon-subunit polypeptide generated by a single nucleotide deletion in acetylcholine receptor deficiency congenital myasthenic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Mutation of the acetylcholine receptor alpha subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Mutations in different functional domains of the human muscle acetylcholine receptor alpha subunit in patients with the slow-channel congenital myasthenic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Seronegative Myasthenia Gravis: Evidence for Plasma Factor(s) Interfering with Acetylcholine Receptor Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Precise epitope mapping of monoclonal antibodies to the cytoplasmic side of the acetylcholine receptor alpha subunit. Dissecting a potentially myasthenogenic epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Immunogenicity of human recombinant acetylcholine receptor alpha subunit: cytoplasmic epitopes dominate the antibody response in four mouse strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Acetylcholine receptor: complex of homologous subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Function of circulating antibody to acetylcholine receptor in myasthenia gravis: Investigation by plasma exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Myasthenia gravis and myasthenic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Antibody heterogeneity and specificity in myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Monoclonal antibodies raised against human acetylcholine receptor bind to all five subunits of the fetal isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Myasthenic Antibodies Cross-Link Acetylcholine Receptors to Accelerate Degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Effect of myasthenic immunoglobulin on acetylcholine receptors of intact mammalian neuromuscular junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

End-plate voltage-gated sodium channels are lost in clinical and experimental myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Maturation of the acetylcholine receptor in skeletal muscle: regulation of the AChR gamma-to-epsilon switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Asymptomatic maternal myasthenia as a cause of the Pena-Shokeir phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Modulation of acetylcholine receptor expression in seronegative myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Quantal components of end-plate potentials in the myasthenic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Calcium channel blockers and transmitter release at the normal human neuromuscular junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Decreased calcium currents in motor nerve terminals of mice with Lambert-Eaton myasthenic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Calcium channels involved in synaptic transmission at the mature and regenerating mouse neuromuscular junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Autoantibody screening in subacute cerebellar ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2000.01785.X

10.1046/J.1432-1033.2000.01785.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference